Insider Trading activities of Applied Genetic Technologies Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Applied Genetic Technologies Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Applied Genetic Technologies Corp since year 2005. Table 2 shows the detailed insider transactions of Applied Genetic Technologies Corp since 2005. The reporting company's ticker symbol is AGTC. The reporting company's CIK number is 1273636.
The total value of stock buying since 2005 is $8,898,889.
The total value of stock sales since 2005 is $12,371,244.
The total value of stock option exercises since 2005 is $93,878.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Applied Genetic Technologies Corp (AGTC).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2016-11 3,000 $28,875 1,000 $7,052 0 $0
2016-10 0 $0 0 $0 1,000 $350
2016-09 14,400 $126,550 0 $0 0 $0
2016-08 0 $0 0 $0 5,328 $18,648
2016-05 0 $0 0 $0 6,000 $21,000
2015-02 0 $0 503,150 $11,069,803 0 $0
2015-01 0 $0 1,996 $49,700 1,996 $9,780
2014-12 0 $0 59,000 $1,244,689 9,000 $44,100
2014-04 728,622 $8,743,464 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Applied Genetic Technologies Corp insiders (AGTC)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-11-16 Magovcevic Ivana (Director) Buy 3,000 9.62 28,875
2016-11-01 Chulay Jeffrey D. (VP and Chief Medical Officer) Sale 1,000 7.05 7,052
2016-10-19 Chulay Jeffrey D. (VP and Chief Medical Officer) Option Ex 1,000 .35 350
2016-09-22 Shearman Mark S (Chief Scientific Officer) Buy 3,000 8.87 26,604
2016-09-20 Potter Stephen W (See Remarks) Buy 400 8.69 3,476
2016-09-19 Bullock Lawrence E (Chief Financial Officer) Buy 10,000 8.75 87,500
2016-09-16 Potter Stephen W (See Remarks) Buy 1,000 8.97 8,970
2016-08-29 Washer Susan B. (See Remarks) Option Ex 5,328 3.50 18,648
2016-05-25 Chulay Jeffrey D. (VP and Chief Medical Officer) Option Ex 2,000 3.50 7,000
2016-05-11 Chulay Jeffrey D. (VP and Chief Medical Officer) Option Ex 4,000 3.50 14,000
2015-02-23 Glaxosmithkline Plc Sale 503,150 22.00 11,069,803
2015-01-23 Menichella Daniel L (V.P. & Chief Business Officer) Sale 1,996 24.90 49,700
2015-01-23 Menichella Daniel L (V.P. & Chief Business Officer) Option Ex 1,996 4.90 9,780
2014-12-22 Menichella Daniel L (V.P. & Chief Business Officer) Sale 9,000 20.83 187,469
2014-12-22 Menichella Daniel L (V.P. & Chief Business Officer) Option Ex 9,000 4.90 44,100
2014-12-18 Glaxosmithkline Plc Sale 12,000 21.01 252,132
2014-12-17 Glaxosmithkline Plc Sale 8,000 21.00 168,000
2014-12-12 Glaxosmithkline Plc Sale 7,500 21.24 159,292
2014-12-11 Glaxosmithkline Plc Sale 12,500 21.28 266,037
2014-12-10 Glaxosmithkline Plc Sale 10,000 21.18 211,759
2014-04-01 Rosen James (Director) Buy 62,871 12.00 754,452
2014-04-01 Carroll Jill (Director) Buy 103,762 12.00 1,245,144
2014-04-01 Wu Samuel (Director) Buy 75,735 12.00 908,820
2014-04-01 Alta Partners Management Viii, Llc (10% Owner) Buy 155,645 12.00 1,867,740
2014-04-01 Medimmune Ventures, Inc. (10% Owner) Buy 75,735 12.00 908,820
2014-04-01 Oronsky Arnold L (Director) Buy 75,736 12.00 908,832
2014-04-01 Cash Harvey B (10% Owner) Buy 75,376 12.00 904,512
2014-04-01 Glaxosmithkline Plc Buy 103,762 12.00 1,245,144

Insider trading activities including stock purchases, stock sales, and option exercises of AGTC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Applied Genetic Technologies Corp (symbol AGTC, CIK number 1273636) see the Securities and Exchange Commission (SEC) website.